↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

77 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   1.2 mg zgn-440 for injectable suspension   -   -   -   -   1件:
193 
 2   1.8 mg zgn-440 for injectable suspension   -   -   -   -   1件:
193 
 3   Acomplia 20 mg film-coated tablets   -   -   -   -   1件:
193 
 4   Acth   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
13,
66,
145,
193,
222 
 5   Anastrozole   Anastrozole   D00960   1件: CYP19A1   3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis   3件:
78,
86,
193 
 6   Azp-531   -   -   -   -   1件:
193 
 7   B. lactis b94   -   -   -   -   1件:
193 
 8   Beloranib   Beloranib   -   -   -   1件:
193 
 9   Byetta   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
193 
 10   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 11   Cannabidiol oral solution   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   4件:
140,
144,
145,
193 
 12   Carbetocin   Carbetocin   D07229   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193 
 13   Cbdv   Cannabidivarin   -   -   -   1件:
193 
 14   Cbdv compound   Cannabidivarin   -   -   -   1件:
193 
 15   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 16   Choline   Choline   D07690   -   -   4件:
65,
171,
193,
299 
 17   Coenzyme q10   Ubidecarenone   D01065   -   -   10件:
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 18   Dccr   -   -   -   -   1件:
193 
 19   Diazoxide   Diazoxide   D00294   2件: ABCC8, KCNJ11   4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   1件:
193 
 20   Diazoxide choline controlled-release tablet   Diazoxide   D00294   2件: ABCC8, KCNJ11   4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   1件:
193 
 21   Eu/1/06/362/003: 5µg (1 pen)   -   -   -   -   1件:
193 
 22   Eutropin   -   -   -   -   2件:
78,
193 
 23   Exenatide   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
193,
233 
 24   Fe 992097   -   -   -   -   1件:
193 
 25   Genotonorm   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
193 
 26   Genotonorm miniquick 0,2 mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
193 
 27   Genotropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
13,
78,
193 
 28   Genotropin (somatropin) is a growth hormone treatment. it is an exact copy of the natural growth hormone that our bodies make. the main difference is that genotropin is man-made.   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
193 
 29   Glwl-01   -   -   -   -   1件:
193 
 30   Growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   11件:
2,
13,
19,
46,
78,
96,
191,
193,
195,
265,
299 
 31   Growth hormone (genotonorm® or omnitrope®)   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   2件:
78,
193 
 32   Guanfacine   Guanfacine   D00606, D08031   1件: ADRA2A   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
193 
 33   Guanfacine extended release (gxr)   Guanfacine   D00606, D08031   1件: ADRA2A   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
193 
 34   Human growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
78,
193,
265 
 35   Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
193 
 36   Inn not yet proposed   -   -   -   -   1件:
193 
 37   Intranasal carbetocin dose 1   Carbetocin   D07229   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193 
 38   Intranasal carbetocin dose 2   Carbetocin   D07229   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193 
 39   Intranasal oxytocin   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   2件:
127,
193 
 40   Intranasal oxytocin (in-oxt)   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193 
 41   Liraglutide   Liraglutide   D06404   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
75,
193 
 42   Livoletide   Livoletide   -   -   -   1件:
193 
 43   Medical air   Medical air   -   -   -   3件:
85,
86,
193 
 44   Medical air vs oxygen   Medical air   -   -   -   1件:
193 
 45   Metoprolol   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
17,
57,
58,
113,
193,
226 
 46   Metoprolol succinate   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
57,
58,
113,
193 
 47   Metoprololsuccinat orion 25mg   -   -   -   -   1件:
193 
 48   Metoprololsuccinat ”orion” 25mg   -   -   -   -   1件:
193 
 49   Metyrapone   Metyrapone   D00410, D05019   1件: CYP11B1   4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis   2件:
75,
193 
 50   Norditropin simplexx   -   -   -   -   4件:
3,
78,
193,
195 
 51   Nutropin aq   -   -   -   -   4件:
78,
134,
193,
299 
 52   Octreotide   Octreotide   D00442, D06495   1件: SSTR2   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   7件:
67,
75,
84,
85,
89,
193,
227 
 53   Omnitrope   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   2件:
78,
193 
 54   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 55   Oxytocin   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   4件:
127,
193,
206,
226 
 56   Oxytocin (oxt) continuous   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193 
 57   Physiological serum (sodium chloride)   Sodium chloride   D02056   -   -   1件:
193 
 58   Probiotic   -   -   -   -   5件:
2,
6,
96,
193,
266 
 59   Recombinant human growth hormon   -   -   -   -   1件:
193 
 60   Recombinant human growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
78,
193,
265 
 61   Recombinant somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
193 
 62   Rimonabant   Rimonabant   D05731   1件: CNR1   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
193 
 63   Rm-493   -   -   -   -   1件:
193 
 64   Sandostatin lar   -   -   -   -   4件:
67,
84,
193,
227 
 65   Saxenda   Liraglutide   D06404   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
193 
 66   Sodium chloride   Sodium chloride   D02056   -   -   13件:
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 67   Somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   15件:
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 68   Subcutaneous beloranib in suspension   Beloranib   -   -   -   1件:
193 
 69   Syntocinon   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   2件:
127,
193 
 70   Syntocinon nasal spray   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193 
 71   Syntocinon®/- spray   -   -   -   -   1件:
193 
 72   Tesofensine   Tesofensine   -   -   -   2件:
6,
193 
 73   Tesofensine/metoprolol   Tesofensine   -   -   -   1件:
193 
 74   Topiramate   Topiramate   D00537   36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   48件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
6,
140,
144,
156,
193 
 75   Zgn-440   -   -   -   -   1件:
193 
 76   Zgn-440 for injectable suspension   -   -   -   -   1件:
193 
 77   Zgn-440 sterile diluent   -   -   -   -   1件:
193 

先頭へ